Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Rubin Grandis

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reviews|April 3, 2004
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigationSufi Mary Thomas, Jennifer Rubin Grandis
Head and Neck Pathology|July 12, 2012
Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerVivian Wai Yan Lui, Jennifer Rubin Grandis
Anticancer Research|May 23, 2002
EGFR-mediated cell cycle regulationVivian Wai Yan Lui, Jennifer Rubin Grandis
Oncogene|December 14, 2004
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapySichuan Xi, William E Gooding, Jennifer Rubin Grandis
Current Gene Therapy|November 30, 2007
Clinical applications of gene therapy in head and neck cancerMichalis V Karamouzis, Athanassios Argiris, Jennifer Rubin Grandis
Advances in Oto-Rhino-Laryngology|December 21, 2004
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapyFrank Riedel, Karl Götte, Karl Hörmann, et al.
The Lancet. Infectious Diseases|January 15, 2004
The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlationsJennifer Rubin Grandis, Barton F Branstetter, Victor L Yu
Expert Opinion on Biological Therapy|March 1, 2006
STAT3 as a therapeutic target in head and neck cancerRebecca J Leeman, Vivian Wai Yan Lui, Jennifer Rubin Grandis
International Journal of Oncology|July 31, 2003
Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivoFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Oncology|June 14, 2002
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migrationFrank Riedel, Karl Götte, Mengfeng Li, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reviews|April 3, 2004
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigationSufi Mary Thomas, Jennifer Rubin Grandis
Head and Neck Pathology|July 12, 2012
Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerVivian Wai Yan Lui, Jennifer Rubin Grandis
Anticancer Research|May 23, 2002
EGFR-mediated cell cycle regulationVivian Wai Yan Lui, Jennifer Rubin Grandis
Oncogene|December 14, 2004
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapySichuan Xi, William E Gooding, Jennifer Rubin Grandis
Current Gene Therapy|November 30, 2007
Clinical applications of gene therapy in head and neck cancerMichalis V Karamouzis, Athanassios Argiris, Jennifer Rubin Grandis
Advances in Oto-Rhino-Laryngology|December 21, 2004
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapyFrank Riedel, Karl Götte, Karl Hörmann, et al.
The Lancet. Infectious Diseases|January 15, 2004
The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlationsJennifer Rubin Grandis, Barton F Branstetter, Victor L Yu
Expert Opinion on Biological Therapy|March 1, 2006
STAT3 as a therapeutic target in head and neck cancerRebecca J Leeman, Vivian Wai Yan Lui, Jennifer Rubin Grandis
International Journal of Oncology|July 31, 2003
Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivoFrank Riedel, Karl Götte, Mengfeng Li, et al.
International Journal of Oncology|June 14, 2002
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migrationFrank Riedel, Karl Götte, Mengfeng Li, et al.
Pageof 6